Yujia Chi
Impact in
-
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- Peptidase Inhibition and Analysis
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Ferroptosis and cancer prognosis
Papers in
-
- Lung Cancer Treatments and Mutations 9
- Lung Cancer Diagnosis and Treatment 7
- Occupational and environmental lung diseases 2
- Oncology 11
- Lung Cancer Research Studies 8
- Cancer Immunotherapy and Biomarkers 3
- Peptidase Inhibition and Analysis 2
- Co-authors
- Minglei Zhuo (15 shared papers)Ziping Wang (14 shared papers)Tongtong An (14 shared papers)Jianjie Li (13 shared papers)Meina Wu (11 shared papers)Jun Zhao (13 shared papers)Xue Yang (11 shared papers)Jia Zhong (8 shared papers)
- Journals
- BMC Cancer (3 papers)BMC Microbiology (1 paper)Frontiers in Oncology (1 paper)Annals of Translational Medicine (1 paper)Cancer Medicine (1 paper)
- Partner nations
- ChinaEthiopiaUnited States
In The Last Decade
Yujia Chi
19 papers receiving 207 citations
Peers
Comparison fields: 5 of 46
- Oncology 110
- Pulmonary and Respiratory Medicine 125
- Cancer Research 21
- Epidemiology 39
- Immunology 21
Countries citing papers authored by Yujia Chi
This map shows the geographic impact of Yujia Chi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yujia Chi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yujia Chi more than expected).
Fields of papers citing papers by Yujia Chi
This network shows the impact of papers produced by Yujia Chi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yujia Chi. The network helps show where Yujia Chi may publish in the future.
Co-authors
The 25 scholars most cited alongside Yujia Chi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 26 | |
| 2 | 2021 | 24 | |
| 3 | 2020 | 19 | |
| 4 | 2022 | 19 | |
| 5 | 2019 | 17 | |
| 6 | 2020 | 16 | |
| 7 | 2019 | 14 | |
| 8 | 2019 | 13 | |
| 9 | 2022 | 12 | |
| 10 | 2020 | 12 | |
| 11 | 2023 | 11 | |
| 12 | 2021 | 7 | |
| 13 | 2021 | 6 | |
| 14 | 2020 | 5 | |
| 15 | 2021 | 4 | |
| 16 | Clinical Characteristics of Cardiac and Pericardial Metastasis in Small Cell Lung Cancer with Arrhythmia | 2021 | 1 |
| 17 | 2024 | 1 | |
| 18 | 2022 | 1 | |
| 19 | 2022 | 1 | |
| 20 | 2025 | 0 |
About Yujia Chi
Yujia Chi is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Epidemiology and Surgery, having authored 20 papers that have together received 209 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Research Studies (8 papers), Lung Cancer Diagnosis and Treatment (7 papers), Neuroendocrine Tumor Research Advances (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Peptidase Inhibition and Analysis (2 papers), Immune Cell Function and Interaction (2 papers) and Occupational and environmental lung diseases (2 papers). The work is most often cited by research in Oncology (110 citations), Pulmonary and Respiratory Medicine (125 citations), Cancer Research (21 citations), Epidemiology (39 citations) and Immunology (21 citations). Yujia Chi has collaborated with scholars based in China, Ethiopia and United States. Frequent co-authors include Minglei Zhuo, Ziping Wang, Tongtong An, Jianjie Li, Meina Wu, Jun Zhao, Xue Yang, Jia Zhong, Xiaoyu Zhai and Hanxiao Chen. Their work appears in journals such as BMC Cancer, BMC Microbiology, Frontiers in Oncology, Annals of Translational Medicine and Cancer Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.